Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in J Magn Reson Imaging

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    October 2018
  1. WANG S, Fan X, Yousuf A, Eggener SE, et al
    Evaluation of Focal Laser Ablation of Prostate Cancer Using High Spectral and Spatial Resolution Imaging: A Pilot Study.
    J Magn Reson Imaging. 2018 Oct 6. doi: 10.1002/jmri.26538.
    PubMed     Text format     Abstract available


    September 2018
  2. CHEN T, Li M, Gu Y, Zhang Y, et al
    Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    J Magn Reson Imaging. 2018 Sep 19. doi: 10.1002/jmri.26243.
    PubMed     Text format     Abstract available


  3. GIROMETTI R, Giannarini G, Greco F, Isola M, et al
    Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.
    J Magn Reson Imaging. 2018 Sep 5. doi: 10.1002/jmri.26220.
    PubMed     Text format     Abstract available


  4. ZHANG Z, Xu H, Xue Y, Li J, et al
    Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
    J Magn Reson Imaging. 2018 Sep 2. doi: 10.1002/jmri.26235.
    PubMed     Text format     Abstract available


    August 2018
  5. WU HH, Priester A, Khoshnoodi P, Zhang Z, et al
    A system using patient-specific 3D-printed molds to spatially align in vivo MRI with ex vivo MRI and whole-mount histopathology for prostate cancer research.
    J Magn Reson Imaging. 2018 Aug 2. doi: 10.1002/jmri.26189.
    PubMed     Text format     Abstract available


    May 2018
  6. SHIRADKAR R, Ghose S, Jambor I, Taimen P, et al
    Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
    J Magn Reson Imaging. 2018 May 7. doi: 10.1002/jmri.26178.
    PubMed     Text format     Abstract available


    April 2018
  7. SONG Y, Zhang YD, Yan X, Liu H, et al
    Computer-aided diagnosis of prostate cancer using a deep convolutional neural network from multiparametric MRI.
    J Magn Reson Imaging. 2018 Apr 16. doi: 10.1002/jmri.26047.
    PubMed     Text format     Abstract available


    March 2018
  8. GAUR S, Harmon S, Mehralivand S, Bednarova S, et al
    Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer.
    J Magn Reson Imaging. 2018 Mar 31. doi: 10.1002/jmri.26025.
    PubMed     Text format     Abstract available


  9. LUZURIER A, Jouve De Guibert PH, Allera A, Feldman SF, et al
    Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.
    J Magn Reson Imaging. 2018 Mar 8. doi: 10.1002/jmri.25991.
    PubMed     Text format     Abstract available


    February 2018
  10. ALGOHARY A, Viswanath S, Shiradkar R, Ghose S, et al
    Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings.
    J Magn Reson Imaging. 2018 Feb 22. doi: 10.1002/jmri.25983.
    PubMed     Text format     Abstract available


  11. WANG J, Wu CJ, Bao ML, Zhang J, et al
    Using support vector machine analysis to assess PartinMR: A new prediction model for organ-confined prostate cancer.
    J Magn Reson Imaging. 2018 Feb 13. doi: 10.1002/jmri.25961.
    PubMed     Text format     Abstract available


  12. LIU W, Liu XH, Tang W, Gao HB, et al
    Histogram analysis of stretched-exponential and monoexponential diffusion-weighted imaging models for distinguishing low and intermediate/high gleason scores in prostate carcinoma.
    J Magn Reson Imaging. 2018 Feb 7. doi: 10.1002/jmri.25958.
    PubMed     Text format     Abstract available


    November 2017
  13. GIGANTI F, Gambarota G, Moore CM, Robertson NL, et al
    Prostate cancer detection using quantitative T2 and T2 -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance.
    J Magn Reson Imaging. 2017 Nov 14. doi: 10.1002/jmri.25891.
    PubMed     Text format     Abstract available


    September 2017
  14. YIM JH, Kim CK, Kim JH
    Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.
    J Magn Reson Imaging. 2017 Sep 13. doi: 10.1002/jmri.25856.
    PubMed     Text format     Abstract available


  15. DWIVEDI DK, Kumar R, Dwivedi AK, Bora GS, et al
    Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL.
    J Magn Reson Imaging. 2017 Sep 4. doi: 10.1002/jmri.25850.
    PubMed     Text format     Abstract available


    June 2017
  16. HEIDKAMP J, Hoogenboom M, Kovacs IE, Veltien A, et al
    Ex vivo MRI evaluation of prostate cancer: Localization and margin status prediction of prostate cancer in fresh radical prostatectomy specimens.
    J Magn Reson Imaging. 2017 Jun 5. doi: 10.1002/jmri.25785.
    PubMed     Text format     Abstract available


    April 2017
  17. KRISHNA S, Lim CS, McInnes MD, Flood TA, et al
    Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer.
    J Magn Reson Imaging. 2017 Apr 7. doi: 10.1002/jmri.25729.
    PubMed     Text format     Abstract available


  18. HELFRICH O, Puech P, Betrouni N, Pincon C, et al
    Quantified analysis of histological components and architectural patterns of gleason grades in apparent diffusion coefficient restricted areas upon diffusion weighted MRI for peripheral or transition zone cancer locations.
    J Magn Reson Imaging. 2017 Apr 6. doi: 10.1002/jmri.25716.
    PubMed     Text format     Abstract available


    March 2017
  19. STRAUB S, Laun FB, Emmerich J, Jobke B, et al
    Potential of quantitative susceptibility mapping for detection of prostatic calcifications.
    J Magn Reson Imaging. 2017;45:889-898.
    PubMed     Text format     Abstract available


    February 2017
  20. WEISS J, Martirosian P, Taron J, Othman AE, et al
    Feasibility of accelerated simultaneous multislice diffusion-weighted MRI of the prostate.
    J Magn Reson Imaging. 2017 Feb 15. doi: 10.1002/jmri.25665.
    PubMed     Text format     Abstract available


    January 2017
  21. SABOURI S, Fazli L, Chang SD, Savdie R, et al
    MR measurement of luminal water in prostate gland: Quantitative correlation between MRI and histology.
    J Magn Reson Imaging. 2017 Jan 27. doi: 10.1002/jmri.25624.
    PubMed     Text format     Abstract available


  22. HECTORS SJ, Besa C, Wagner M, Jajamovich GH, et al
    DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    J Magn Reson Imaging. 2017 Jan 16. doi: 10.1002/jmri.25631.
    PubMed     Text format     Abstract available


    November 2016
  23. LIM CS, McInnes MD, Lim RS, Breau RH, et al
    Prognostic value of Prostate Imaging and Data Reporting System (PI-RADS) v. 2 assessment categories 4 and 5 compared to histopathological outcomes after radical prostatectomy.
    J Magn Reson Imaging. 2016 Nov 3. doi: 10.1002/jmri.25539.
    PubMed     Text format     Abstract available


    October 2016
  24. PARK JJ, Park BK
    Role of PI-RADSv2 with multiparametric MRI in determining who needs active surveillance or definitive treatment according to PRIAS.
    J Magn Reson Imaging. 2016 Oct 26. doi: 10.1002/jmri.25534.
    PubMed     Text format     Abstract available


    August 2016
  25. WEIS J, von Below C, Tolf A, Ortiz-Nieto F, et al
    Quantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging.
    J Magn Reson Imaging. 2016 Aug 24. doi: 10.1002/jmri.25443.
    PubMed     Text format     Abstract available


  26. BRUNSING RL, Schenker-Ahmed NM, White NS, Parsons JK, et al
    Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.
    J Magn Reson Imaging. 2016 Aug 16. doi: 10.1002/jmri.25419.
    PubMed     Text format     Abstract available


    July 2016
  27. AGARWAL HK, Mertan FV, Sankineni S, Bernardo M, et al
    Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone.
    J Magn Reson Imaging. 2016 Jul 7. doi: 10.1002/jmri.25353.
    PubMed     Text format     Abstract available


    June 2016
  28. GINSBURG SB, Taimen P, Merisaari H, Vainio P, et al
    Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
    J Magn Reson Imaging. 2016 Jun 10. doi: 10.1002/jmri.25330.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: